NCT07275502

Brief Summary

Difficult facemask ventilation remains poorly classified. Existing definitions rely on expert opinion and subjective rating of surrogates. This lack of standardization has led to highly variable reported incidences and inconsistencies in clinical practice and research. This secondary analysis of the prospective observational MASCAN study aims to develop and validate a data-driven objective classification system for difficult facemask ventilation and to determine its diagnostic performance and calibration. Facemask ventilation was facilitated after anaesthesia induction in all patients. An independent observer systematically assessed potential indicators for difficult facemask ventilation that serve as candidate predictor variables for the fitting of a diagnostic multivariable logistic regression model and simplified score to classify difficult facemask ventilation. Cross-validated LASSO regression will be used for variable selection. The area under the receiver operating characteristic curve (AUROC) and calibration curves will be used to quantify the diagnostic performance and calibration, and optimal decision thresholds will be defined.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
423

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2025

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
Last Updated

December 10, 2025

Status Verified

November 1, 2025

Enrollment Period

6 months

First QC Date

November 27, 2025

Last Update Submit

November 27, 2025

Conditions

Keywords

Difficult facemask ventilation

Outcome Measures

Primary Outcomes (1)

  • Difficult facemask ventilation

    Alert documented in patients' health records by the airway operator following facemask ventilation (y/n)

    1 hour

Secondary Outcomes (2)

  • Impossible facemask ventilation

    1 hour

  • Airway-related adverse events

    1 hour

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive sampling: Adult patients that undergo ENT or OMS surgery in a tertiary care hospital who require facemask ventilation and tracheal intubation after induction of anesthesia.

You may qualify if:

  • Patients scheduling for ENT or OMS surgery in general anaesthesia, who require facemask ventilation and tracheal intubation after induction of anesthesia
  • Patients aged at least 18 years
  • Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
  • The patient is co-operative and available for the entire study
  • Provided informed consent/patient representative

You may not qualify if:

  • Pregnant or breastfeeding woman
  • Rapid sequence induction or other contraindications for facemask ventilation
  • Planned awake tracheal intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, Center for Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf

Hamburg, 20246, Germany

Location

Study Officials

  • Martin Petzoldt, MD

    University Medical Centre Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2025

First Posted

December 10, 2025

Study Start

November 7, 2022

Primary Completion

May 15, 2023

Study Completion

November 30, 2025

Last Updated

December 10, 2025

Record last verified: 2025-11

Locations